Literature DB >> 8352890

Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: possible alternative mechanisms of human colon carcinogenesis.

H Kakiuchi1, T Ushijima, M Ochiai, K Imai, N Ito, A Yachi, T Sugimura, M Nagao.   

Abstract

Heterocyclic amines present in cooked foods are known to produce colon tumors in F344 rats at a high incidence, indicating the possibility of involvement of ras gene activation in colon carcinogenesis in rats as in humans. We examined mutations at codons 12, 13, and 61 of the Ki-ras, Ha-ras, and N-ras genes by polymerase chain reaction--direct sequencing in seven colon tumors in F344 rats induced by 2-amino-6-methyldipyrido-[1,2-a:3',2'-d]imidazole (Glu-P-1), 11 induced by 2-amino-3-methylimidazo[4,5-f]quinoline, and nine induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. A Ki-ras gene mutation (G-->T at the second position in codon 12) was found in one Glu-P-1-induced colon adenocarcinoma. None of the other 26 tumors had mutations in any of these three ras family genes. These results indicate that in rats, colon carcinogenesis induced by heterocyclic amines may be induced by alterations of other oncogenes or tumor suppressor genes. We think this experimental system using carcinogens to which humans are exposed is a good model for studying alterations of other genes in human colon tumors in which no Ki-ras alterations are observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352890     DOI: 10.1002/mc.2940080110

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  9 in total

1.  Differences in carcinogenesis by the length of carcinogen exposure period in rat colon.

Authors:  T Endo; K Ookawa; M Tanaka; S Nakaji; S Tsuchida; K Sugawara
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Synthesis of oligonucleotides containing the N2-deoxyguanosine adduct of the dietary carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline.

Authors:  James S Stover; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2007-10-04       Impact factor: 3.739

Review 3.  Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.

Authors:  Denis E Corpet; Fabrice Pierre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

4.  Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer.

Authors:  Eva Morales; Miquel Porta; Jesús Vioque; Tomás López; Michelle A Mendez; José Pumarega; Núria Malats; Marta Crous-Bou; Joy Ngo; Juli Rifà; Alfredo Carrato; Luisa Guarner; Josep M Corominas; Francisco X Real
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

5.  Specific 5'-GGGA-3'-->5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  H Kakiuchi; M Watanabe; T Ushijima; M Toyota; K Imai; J H Weisburger; T Sugimura; M Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 6.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

Review 7.  Mouse models of colorectal cancer.

Authors:  Yunguang Tong; Wancai Yang; H Phillip Koeffler
Journal:  Chin J Cancer       Date:  2011-07

Review 8.  Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals.

Authors:  M Nagao; K Wakabayashi; T Ushijima; M Toyota; Y Totsuka; T Sugimura
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

9.  Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole, 2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo]4,5-b]pyridine.

Authors:  H Makino; T Ushijima; H Kakiuchi; M Onda; N Ito; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.